Skip to content
IeDEA International epidemiology Databases to Evaluate AIDS

IeDEA International epidemiology Databases to Evaluate AIDS

0Countries
0Sites
>0People living with and at risk for HIV
  • Home
    • Who We Are
  • Regions
    • Asia-Pacific
    • CCASAnet
    • Central Africa
    • East Africa
    • NA-ACCORD
    • Southern Africa
    • West Africa
  • Working Groups
    • Executive Committee
    • Adolescent and Young Adult Network of IeDEA (AYANI)
    • Cancer
    • Data Harmonization
    • Fogarty-IeDEA Mentorship Program (FIMP)
    • Hepatitis
    • Mental Health
    • Mother and Infant
    • Pediatrics
    • Sentinel Research Network (SRN)
    • Site Assessment
    • Strategic Data
    • Substance Use
    • Tuberculosis and Lung Health
  • Publications
    • Asia-Pacific
    • CCASAnet
    • Central Africa
    • East Africa
    • NA-ACCORD
    • Southern Africa
    • West Africa
    • Multi-regional
    • All publications
  • Resources
    • Fogarty-IeDEA Mentorship Program (FIMP)
    • Multiregional research SOPs, templates
    • Funding Acknowledgements
    • Consortium accomplishments
    • Meeting reports and presentations
      • CROI 2022 – IeDEA presentations
  • News
IeDEA International epidemiology Databases to Evaluate AIDS > Resources > Meeting reports and presentations

Meeting reports and presentations

Global IeDEA Meeting 2021

Link to early-stage investigator video posters

All-Africa Regional Meeting 2019 (Johannesburg, SA)

Link to Meeting Agenda and Slides

All-Africa Regional Meeting 2017 (Kigali, Rwanda)

All-Africa Regional Meeting: Agenda and Slides

News

  • Global Newsletter – SeptemberSeptember 26, 2024
  • Global Newsletter – JulyJuly 19, 2024
  • Global Newsletter – AprilApril 2, 2024
  • Global Newsletter – JanuaryJanuary 24, 2024
  • New Fogarty-IeDEA Mentorship Program (FIMP) traineesDecember 8, 2023

Quick access

  • Who We Are
  • Regions
  • Working Groups
  • Publications
  • Resources

News

Global Newsletter – September

Read our latest global newsletter here.

Global Newsletter – July

Read our latest global newsletter here.

Global Newsletter – April

Read our latest global newsletter here.

Global Newsletter – January

Read our latest global newsletter here.

New Fogarty-IeDEA Mentorship Program (FIMP) trainees

IeDEA has selected 13 new FIMP trainees from 13 countries to join our regional programs in January 2024. 

Recent publications

2775998 369YB7BV 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 3 default desc 2112 https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22DH7Q539B%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zaniewski%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EZaniewski%2C%20Elizabeth%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESkrivankova%2C%20Veronika%20Whitesell%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20Ellen%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAvihingsanon%2C%20Anchalee%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECardoso%2C%20Sandra%20Wagner%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282024%29.%20Transition%20to%20dolutegravir-based%20ART%20in%2035%20low-%20and%20middle-income%20countries%3A%20a%20global%20survey%20of%20HIV%20care%20clinics.%20%3Ci%3EAIDS%20%28London%2C%20England%29%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004007%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004007%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transition%20to%20dolutegravir-based%20ART%20in%2035%20low-%20and%20middle-income%20countries%3A%20a%20global%20survey%20of%20HIV%20care%20clinics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronika%20Whitesell%22%2C%22lastName%22%3A%22Skrivankova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anchalee%22%2C%22lastName%22%3A%22Avihingsanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henri%22%2C%22lastName%22%3A%22Chenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rossana%20A.%22%2C%22lastName%22%3A%22Ditangco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Vanes%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20George%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%20Madalitso%22%2C%22lastName%22%3A%22Huwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%20Kouassi%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20Kla%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Muleebwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Mundhe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%20R.%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambou%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20M.%22%2C%22lastName%22%3A%22Obatsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%20Walter%22%2C%22lastName%22%3A%22Prozesky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Supattra%22%2C%22lastName%22%3A%22Rungmaitree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%20Semwendero%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moussa%22%2C%22lastName%22%3A%22Seydi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nosisa%22%2C%22lastName%22%3A%22Sipambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tavitiya%22%2C%22lastName%22%3A%22Sudjaritruk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Tiendrebeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20We%20studied%20the%20transition%20to%20dolutegravir-containing%20antiretroviral%20therapy%20%28ART%29%20at%20HIV%20treatment%20clinics%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%5CnDESIGN%3A%20Site-level%20survey%20conducted%20in%202020-2021%20among%20HIV%20clinics%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29.%5CnMETHODS%3A%20We%20assessed%20the%20status%20of%20dolutegravir%20rollout%20and%20viral%20load%20and%20drug%20resistance%20testing%20practices%20for%20patients%20on%20ART%20switching%20to%20dolutegravir-based%20regimens.%20We%20used%20generalized%20estimating%20equations%20to%20assess%20associations%20between%20clinic%20rollout%20of%20both%20first-%20and%20second-line%20dolutegravir-based%20ART%20regimens%20%28dual%20rollout%29%20and%20site-level%20factors.%5CnRESULTS%3A%20Of%20179%20surveyed%20clinics%2C%20175%20%2898%25%29%20participated%3B%20137%20%2878%25%29%20from%20Africa%2C%2030%20%2817%25%29%20from%20the%20Asia-Pacific%2C%20and%208%20%285%25%29%20from%20Latin%20America.%20Most%20clinics%20%2880%25%29%20were%20in%20low-%20or%20lower-middle-income%20countries%2C%20and%20there%20were%20a%20mix%20of%20primary-%2C%20secondary-%20and%20tertiary-level%20clinics.%20Ninety%20percent%20reported%20rollout%20of%20first-line%20dolutegravir%2C%2059%25%20of%20second-line%2C%2094%25%20of%20first-%20or%20second-line%20and%2055%25%20of%20dual%20rollout.%20The%20adjusted%20odds%20of%20dual%20rollout%20were%20higher%20among%20tertiary-level%20%28aOR%204.00%3B%2095%25%20CI%201.39%20to%2011.47%29%20and%20secondary-level%20clinics%20%28aOR%203.66%3B%2095%25%20CI%202.19%20to%206.11%29%20than%20in%20primary-level%20clinics.%20Over%20half%20%2859%25%29%20of%20clinics%20that%20introduced%20first-%20or%20second-line%20dolutegravir-based%20ART%20required%20recent%20viral%20load%20testing%20before%20switching%20to%20dolutegravir%2C%20and%2015%25%20performed%20genotypic%20resistance%20testing%20at%20switch.%5CnCONCLUSIONS%3A%20Dolutegravir-based%20ART%20was%20rolled%20out%20at%20nearly%20all%20IeDEA%20clinics%20in%20LMICs%2C%20yet%20many%20switched%20patients%20to%20dolutegravir%20without%20recent%20viral%20load%20testing%20and%20drug%20resistance%20testing%20was%20rarely%20performed.%20Without%20such%20testing%2C%20drug%20resistance%20among%20patient%20switching%20to%20dolutegravir%20may%20go%20undetected.%22%2C%22date%22%3A%222024-09-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000004007%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22369YB7BV%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222024-10-09T09%3A20%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22CTS44ZKW%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuniholm%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKuniholm%2C%20Mark%20H.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMurenzi%2C%20Gad%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EShumbusho%2C%20Fabienne%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20Ellen%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EPlaisy%2C%20Marie%20K.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282024%29.%20Association%20of%20cardiovascular%20disease%20risk%20with%20liver%20steatosis%20and%20fibrosis%20in%20people%20living%20with%20hiv%20in%20low-%20and%20middle-income%20countries.%20%3Ci%3EAIDS%20%28London%2C%20England%29%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004012%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004012%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20cardiovascular%20disease%20risk%20with%20liver%20steatosis%20and%20fibrosis%20in%20people%20living%20with%20hiv%20in%20low-%20and%20middle-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20H.%22%2C%22lastName%22%3A%22Kuniholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Shumbusho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20K.%22%2C%22lastName%22%3A%22Plaisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ephrem%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlotta%22%2C%22lastName%22%3A%22Riebensahm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%20V.%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niharika%22%2C%22lastName%22%3A%22Samala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%20S.%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thida%22%2C%22lastName%22%3A%22Chanyachukul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohidas%22%2C%22lastName%22%3A%22Borse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dung%20T.%20H.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez-Iniguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20understand%20the%20relationship%20between%20cardiovascular%20disease%20%28CVD%29%20risk%20and%20liver%20steatosis%20and%20fibrosis%20among%20people%20living%20with%20HIV%20%28PLWH%29%20%5Cu226540%5Cu200ayears%20on%20antiretroviral%20therapy%20%28ART%29%20in%20low-%20and%20middle-income%20countries%20%28LMIC%29.%5CnDESIGN%3A%20We%20used%20cross-sectional%20behavioral%20and%20clinical%20data%20collected%20during%20study%20enrollment%20visits%20in%202020-2022%20for%20the%20Sentinel%20Research%20Network%20of%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28SRN%20of%20IeDEA%29.%5CnMETHODS%3A%20Ten-year%20CVD%20risk%20was%20calculated%20using%202019%20World%20Health%20Organization%20non-laboratory%20and%20laboratory%20models.%20Transient%20elastography%20%28TE%29%20was%20used%20to%20assess%20liver%20disease.%20Presence%20of%20steatosis%20and%20significant%20fibrosis%20were%20defined%20by%20Controlled%20Attenuation%20Parameter%20%28CAP%29%20%5Cu2265248%5Cu200adB%5C%2Fm%20and%20liver%20stiffness%20measurement%20%28LSM%29%20%5Cu22657.1%5Cu200akPa%2C%20respectively.%20Participants%20with%20viral%20hepatitis%2C%20hazardous%20alcohol%20consumption%20and%20unsuppressed%20HIV%20viral%20load%20were%20excluded%20from%20the%20analysis.%20Logistic%20regression%20was%20used%20to%20estimate%20odds%20ratios%2C%20adjusting%20for%20study%20site%2C%20CD4%5Cu200aT%20cell%20count%2C%20stavudine%20and%20didanosine%20exposure%2C%20and%20in%20models%20stratified%20by%20sex%20and%20geographic%20region.%5CnRESULTS%3A%20There%20were%201%2C750%20participants%20from%20nine%20LMIC.%20Median%20CVD%20risk%20was%203%25%20for%20both%20non-laboratory%20and%20laboratory-based%20models.%20Adjusted%20odds%20ratios%20%28ORs%29%20for%20steatosis%20and%20significant%20fibrosis%20associated%20with%20laboratory%20CVD%20risk%20%28%5Cu226510%25%20vs.%20%3C5%25%29%20were%20OR%5Cu200a%3D%5Cu200a1.83%20%2895%25%20confidence%20interval%3A%28CI%29%5Cu200a%3D%5Cu200a1.21-2.76%3B%20P%5Cu200a%3D%5Cu200a0.004%29%20and%20OR%5Cu200a%3D%5Cu200a1.62%20%2895%25%20CI%5Cu200a%3D%5Cu200a0.85-3.07%3B%20P%5Cu200a%3D%5Cu200a0.14%29%2C%20respectively.%20Associations%20of%20CVD%20risk%20with%20steatosis%20were%20stronger%20in%20males%20and%20among%20participants%20at%20study%20sites%20outside%20Africa.%5CnCONCLUSIONS%3A%20Higher%20CVD%20risk%20was%20associated%20with%20steatosis%20but%20not%20with%20significant%20fibrosis%20in%20PLWH%20in%20our%20LMIC%20cohort.%22%2C%22date%22%3A%222024-09-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000004012%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22369YB7BV%22%2C%22NMNPNZRP%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222024-10-09T09%3A16%3A09Z%22%7D%7D%2C%7B%22key%22%3A%224HQSQPK4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222024-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EParcesepe%2C%20Angela%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EStockton%2C%20Melissa%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBernard%2C%20Charlotte%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKanguya%2C%20Tukiya%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKwobah%2C%20Edith%20Kamaru%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282024%29.%20Prevalence%20and%20co-occurrence%20of%20symptoms%20of%20mental%20and%20substance%20use%20disorders%20among%20people%20with%20HIV%20age%2040%20and%20older%20in%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study.%20%3Ci%3EJournal%20of%20the%20International%20AIDS%20Society%3C%5C%2Fi%3E%2C%20%3Ci%3E27%3C%5C%2Fi%3E%20%2810%29%2C%20S.%20e26359.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26359%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26359%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prevalence%20and%20co-occurrence%20of%20symptoms%20of%20mental%20and%20substance%20use%20disorders%20among%20people%20with%20HIV%20age%2040%20and%20older%20in%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Stockton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tukiya%22%2C%22lastName%22%3A%22Kanguya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Kamaru%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%22%2C%22lastName%22%3A%22Goodrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Musabyimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Smita%22%2C%22lastName%22%3A%22Nimkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22IeDEA%22%2C%22lastName%22%3A%22Consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Due%20to%20the%20increased%20effectiveness%20of%20and%20access%20to%20antiretroviral%20therapy%20%28ART%29%2C%20people%20with%20HIV%20%28PWH%29%20are%20living%20longer.%20As%20a%20result%2C%20the%20population%20of%20older%20PWH%20has%20increased.%20Mental%20and%20substance%20use%20disorders%20%28MSDs%29%20are%20common%20and%20frequently%20co-occurring%20among%20PWH%20and%20are%20associated%20with%20poor%20HIV%20care%20outcomes.%20Research%20into%20the%20prevalence%20and%20co-occurrence%20of%20MSDs%20among%20ageing%20PWH%20remains%20limited%2C%20particularly%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29.%5CnMETHODS%3A%20We%20analysed%20data%20collected%20between%202020%20and%202022%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Sentinel%20Research%20Network%20cohort%20of%20PWH%20aged%2040%20years%20or%20older%20on%20ART%20at%2011%20HIV%20clinics%20in%20Brazil%2C%20C%5Cu00f4te%20d%27Ivoire%2C%20India%2C%20Kenya%2C%20Mexico%2C%20Uganda%2C%20Rwanda%2C%20Togo%2C%20Vietnam%2C%20Zambia%20and%20Zimbabwe.%20We%20estimated%20the%20prevalence%20and%20co-occurrence%20of%20unhealthy%20alcohol%20use%20%28AUDIT-C%20%5Cu22653%20for%20women%2C%20%5Cu22654%20for%20men%29%2C%20unhealthy%20drug%20use%20%28ASSIST%20%3E3%20for%20cannabis%2C%20cocaine%2C%20amphetamines%2C%20inhalants%2C%20sedatives%2C%20hallucinogens%20and%5C%2For%20opioids%29%2C%20and%20moderate%20to%20severe%20symptoms%20of%20depression%20%28PHQ-9%20%5Cu226510%29%2C%20anxiety%20%28GAD-7%20%5Cu226510%29%20and%20post-traumatic%20stress%20disorder%20%28PTSD%29%20%28PCL-5%20%5Cu226533%29.%20Psychiatric%20multimorbidity%20was%20defined%20as%20having%20symptoms%20of%20two%20or%20more%20disorders%20assessed.%20Log%20binomial%20models%20assessed%20the%20association%20between%20socio-demographic%20and%20HIV%20care%20characteristics%20and%20symptoms%20of%20anxiety%2C%20depression%2C%20PTSD%20or%20unhealthy%20substance%20use.%5CnRESULTS%3A%20Of%202821%20participants%2C%20the%20prevalence%20of%20unhealthy%20alcohol%20and%20drug%20use%20was%2021%25%20and%205%25%2C%20respectively.%20The%20prevalence%20of%20moderate%20to%20severe%20symptoms%20of%20depression%2C%20anxiety%20and%20PTSD%20was%2014%25%2C%209%25%20and%206%25%2C%20respectively.%20Overall%2C%20the%20prevalence%20of%20psychiatric%20multimorbidity%20was%2011%25.%20Among%20those%20with%20symptoms%20of%20at%20least%20one%20mental%20health%20or%20substance%20use%20outcome%20assessed%20%28n%20%3D%201036%29%2C%20the%20prevalence%20of%20psychiatric%20multimorbidity%20was%2031%25.%20In%20binomial%20models%2C%20the%20prevalence%20of%20symptoms%20of%20depression%20and%20anxiety%20was%20higher%2C%20while%20the%20prevalence%20of%20unhealthy%20alcohol%20and%20drug%20use%20was%20lower%20among%20women%20than%20men.%5CnCONCLUSIONS%3A%20Unhealthy%20alcohol%20use%20and%20symptoms%20of%20depression%20were%20most%20commonly%20reported%2C%20among%20this%20cohort%20of%20PWH%20aged%2040%20or%20older%20across%2011%20LMICs.%20Integration%20of%20MSD%20screening%20and%20treatment%20into%20HIV%20care%20should%20be%20prioritized.%20The%20effectiveness%20and%20implementation%20of%20transdiagnostic%20or%20multi-focus%20mental%20health%20treatment%20approaches%20in%20HIV%20care%20settings%20should%20be%20examined.%22%2C%22date%22%3A%222024-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26359%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22369YB7BV%22%2C%22NMNPNZRP%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222024-10-09T09%3A11%3A33Z%22%7D%7D%5D%7D
Zaniewski, Elizabeth; Skrivankova, Veronika Whitesell; Brazier, Ellen; Avihingsanon, Anchalee; Cardoso, Sandra Wagner et al. (2024). Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000004007.
Kuniholm, Mark H.; Murenzi, Gad; Shumbusho, Fabienne; Brazier, Ellen; Plaisy, Marie K. et al. (2024). Association of cardiovascular disease risk with liver steatosis and fibrosis in people living with hiv in low- and middle-income countries. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000004012.
Parcesepe, Angela M.; Stockton, Melissa; Bernard, Charlotte; Kanguya, Tukiya; Kwobah, Edith Kamaru et al. (2024). Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study. Journal of the International AIDS Society, 27 (10), S. e26359. http://doi.org/10.1002/jia2.26359.
  • Home
    • Who We Are
  • Regions
    • Asia-Pacific
    • CCASAnet
    • Central Africa
    • East Africa
    • NA-ACCORD
    • Southern Africa
    • West Africa
  • Working Groups
    • Executive Committee
    • Adolescent and Young Adult Network of IeDEA (AYANI)
    • Cancer
    • Data Harmonization
    • Fogarty-IeDEA Mentorship Program (FIMP)
    • Hepatitis
    • Mental Health
    • Mother and Infant
    • Pediatrics
    • Sentinel Research Network (SRN)
    • Site Assessment
    • Strategic Data
    • Substance Use
    • Tuberculosis and Lung Health
  • Publications
    • Asia-Pacific
    • CCASAnet
    • Central Africa
    • East Africa
    • NA-ACCORD
    • Southern Africa
    • West Africa
    • Multi-regional
    • All publications
  • Resources
    • Fogarty-IeDEA Mentorship Program (FIMP)
    • Multiregional research SOPs, templates
    • Funding Acknowledgements
    • Consortium accomplishments
    • Meeting reports and presentations
      • CROI 2022 – IeDEA presentations
  • News
IeDEA International epidemiology Databases to Evaluate AIDS Proudly powered by WordPress

This site was developed by the Institute of Social and Preventive Medicine (ISPM) at the University of Bern for NIAID, under cooperative agreement number U01AI069924. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the NIAID or the U.S. Government.
Sponsored by: NIAID, NCI, NICHD, NIMH, NHLBI, NIDDK, NLM, NIAAA, FIC and NIDA.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok